ストックスクリーナーアプリを入手
9.1362
5.50%
0.4762
前日終値:
$8.66
開ける：
$8.5
24時間の取引高:
17,757
Relative Volume:
0.02
時価総額：
$5.33M
収益：
$856.00K
当期純損益:
$-12.56M
株価収益率:
-0.0395
EPS:
-231.4926
ネットキャッシュフロー:
$-4.14M
1週間 パフォーマンス:
-20.83%
1か月 パフォーマンス:
+50.76%
6か月 パフォーマンス:
-46.85%
1年 パフォーマンス:
+207.15%
1日の値動き範囲:
$8.50
$9.37
1週間の範囲:
$8.41
$11.98
52週間の値動き範囲:
$2.61
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
9.30 | 4.96M | 856.00K | -12.56M | -4.14M | -231.49 |
VRTX
Vertex Pharmaceuticals Inc
|
444.34 | 110.59B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
616.40 | 63.08B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
894.85 | 53.62B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
292.53 | 38.88B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
149.06 | 30.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Scisparc Ltd (SPRC) 最新ニュース
SciSparc Ltd. Ordinary Shares Stock Short Interest Rises to 66.94% - Moomoo
SPRC Stock Price, Quote & Chart - ChartMill
SciSparc Ltd.'s Equity Buyback announced on July 7, 2022, has expired. - marketscreener.com
Why is SciSparc stock skyrocketing on Thursday? - MSN
SciSparc more than doubles as NeuroThera wins conditional nod for CliniQuantum deal - MSN
NeuroThera completes acquisition of 54% stake in CliniQuantum - Investing.com UK
In today's session, these stocks are experiencing unusual volume. - ChartMill
Which stocks are gapping on Thursday? - ChartMill
SPRC Stock Pops As SciSparc Pushes Into Quantum Clinical Analytics - timothysykes.com
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum - TipRanks
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
NeuroThera completes acquisition of 54% stake in CliniQuantum By Investing.com - Investing.com India
SciSparc (NASDAQ: SPRC) unit NeuroThera acquires 54% of CliniQuantum in CAD$9.46M share deal - Stock Titan
Quantum trial-analysis startup CliniQuantum sold in C$9.5M SciSparc deal - Stock Titan
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Completes Acquisition of 54% Stake in CliniQuantum Ltd. - Quiver Quantitative
NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. - Yahoo Finance
Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - marketscreener.com
SciSparc's Quantum Gambit: Betting on AI to Remake Drug Trials - BriefGlance
Director Itschak Shrem Sells Shares of SciSparc Ltd (SPRC) - GuruFocus
SciSparc (SPRC) director Itschak Shrem sells 462 Ordinary Shares at $10 - Stock Titan
SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline - Bez Kabli
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms - TipRanks
SciSparc (Nasdaq: SPRC) unit to buy 54% of CliniQuantum in share deal - Stock Titan
SciSparc stock surges 200% on NeuroThera acquisition progress - Investing.com
Top Biotech Gainers: SPRC Deal Gets Nod, CODX Rallies, OTLK, AKTX, FTRE Drawing Investor Interest - RTTNews
SciSparc Ltd. (SPRC) Stock: Shares Soar 202% on NeuroThera’s TSX Approval - MEXC
SciSparc stock surges 157% after subsidiary gets conditional TSX approval for major acquisition - Pluang
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera’s TSX Exchange Milestone - MEXC
SciSparc Jumps 150.8% as Subsidiary Wins Conditional Exchange Approval for CliniQuantum Deal - Moomoo
SciSparc jumps 150.8% as subsidiary wins conditional exchange approval for CliniQuantum deal - Quiver Quantitative
Why Is SciSparc Stock Skyrocketing On Thursday? - Benzinga
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera's TSX Exchange Milestone - Blockonomi
SciSparc (SPRC) Stock Rockets 202% as NeuroThera Gets TSX Green Light - MoneyCheck
NeuroThera receives conditional approval for CliniQuantum deal - Investing.com UK
SciSparc stock surges 200% on NeuroThera acquisition progress By Investing.com - Investing.com India
SciSparc’s NeuroThera Labs Gets Conditional Approval to Acquire CliniQuantum - geneonline.com
Trending Stocks Today | SciSparc Shoots up 219.58% - Moomoo
SPRC Stock Explodes As Bullish Upgrades Hit Tape - StocksToTrade
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - markets.businessinsider.com
NeuroThera receives conditional approval for CliniQuantum deal By Investing.com - Investing.com Nigeria
SPRC Stock Draws Bullish Upgrades As Traders Circle - timothysykes.com
Scisparc Ltd (SPRC) 財務データ
収益
当期純利益
現金流量
EPS
1.02%
2.34%
大文字化:
|
ボリューム (24 時間):